Thursday, April 09, 2020 9:26:08 AM
Todos Medical Provides Corporate Update
Press Release | 04/09/2020
Corona Diagnostics JV adds COVID-19 EUA-submitted point-of-care antibody test kit suppliers
Ongoing pre-commercial clinical trial for TMB-1 and TMB-2 progressing despite COVID-19
Full acquisition of Breakthrough Diagnostics JV pending completion of independent valuation
Acquisition of Provista Diagnostics and related Nasdaq listing remain on track for Q2/2020
We remain on track to complete the proposed listing of Todos’ shares onto the Nasdaq CM™ marketplace, as well as complete the acquisition of Provista Diagnostics in the second quarter of 2020 to gain ownership of its proprietary commercial-stage negative predictive value breast cancer blood test Videssa® and its CLIA/CAP certified lab.
Take Profits Relentlessly...Candlesticks the art of learning how to buy Bearish before it turns to Bullish and how to sell the Bullish before it turns Bearish...
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM